Holdenrieder S - Search Results

1

In Response to "Serum Tumor Marker Use in Patients With Advanced Solid Tumors".

Dayyani F, Morgenstern D, Holdenrieder S. Dayyani F, et al. Among authors: holdenrieder s. J Oncol Pract. 2016 Mar;12(3):273-4. doi: 10.1200/JOP.2015.009241. Epub 2016 Feb 2. J Oncol Pract. 2016. PMID: 26837562 No abstract available.

2

Prognostic and therapeutic significance of carbohydrate antigen 19-9 as tumor marker in patients with pancreatic cancer.

Boeck S, Stieber P, Holdenrieder S, Wilkowski R, Heinemann V. Boeck S, et al. Among authors: holdenrieder s. Oncology. 2006;70(4):255-64. doi: 10.1159/000094888. Epub 2006 Aug 4. Oncology. 2006. PMID: 16899980 Free article. Review.

3

Clinically Meaningful Use of Blood Tumor Markers in Oncology.

Holdenrieder S, Pagliaro L, Morgenstern D, Dayyani F. Holdenrieder S, et al. Biomed Res Int. 2016;2016:9795269. doi: 10.1155/2016/9795269. Epub 2016 Nov 30. Biomed Res Int. 2016. PMID: 28042579 Free PMC article. Review.

4

Carcinoembryonic antigen and cytokeratin-19 fragments for assessment of therapy response in non-small cell lung cancer: a systematic review and meta-analysis.

Holdenrieder S, Wehnl B, Hettwer K, Simon K, Uhlig S, Dayyani F. Holdenrieder S, et al. Br J Cancer. 2017 Apr 11;116(8):1037-1045. doi: 10.1038/bjc.2017.45. Epub 2017 Mar 9. Br J Cancer. 2017. PMID: 28278517 Free PMC article. Review.

5

Technical and clinical performance of a new assay to detect squamous cell carcinoma antigen levels for the differential diagnosis of cervical, lung, and head and neck cancer.

Holdenrieder S, Molina R, Qiu L, Zhi X, Rutz S, Engel C, Kasper-Sauer P, Dayyani F, Korse CM. Holdenrieder S, et al. Tumour Biol. 2018 Apr;40(4):1010428318772202. doi: 10.1177/1010428318772202. Tumour Biol. 2018. PMID: 29701125 Free article.

6

A continuous responder algorithm to optimize clinical management of small-cell lung cancer with progastrin-releasing peptide as a simple blood test.

Muley T, Zhang X, Holdenrieder S, Korse CM, Zhi XY, Molina R, Liu Z, Hartmann G, van den Heuvel MM, Qian K, Marrades R, Engel C, He Y, Wehnl B, Dayyani F, Herth F. Muley T, et al. Among authors: holdenrieder s. Tumour Biol. 2020 Sep;42(9):1010428320958603. doi: 10.1177/1010428320958603. Tumour Biol. 2020. PMID: 32964798 Free article.

7

Apoptosis in serum of patients with solid tumours.

Holdenrieder S, Stieber P, Förg T, Kühl M, Schulz L, Busch M, Schalhorn A, Seidel D. Holdenrieder S, et al. Anticancer Res. 1999 Jul-Aug;19(4A):2721-4. Anticancer Res. 1999. PMID: 10470228

8

Cytokeratin serum biomarkers in patients with colorectal cancer.

Holdenrieder S, Stieber P, Liska V, Treska V, Topolcan O, Dreslerova J, Matejka VM, Finek J, Holubec L. Holdenrieder S, et al. Anticancer Res. 2012 May;32(5):1971-6. Anticancer Res. 2012. PMID: 22593474

9

Soluble receptor of advanced glycation end products (sRAGE) indicates response to chemotherapy in pancreatic cancer patients.

Wittwer C, Boeck S, Heinemann V, Haas M, Stieber P, Nagel D, Holdenrieder S. Wittwer C, et al. Among authors: holdenrieder s. Int J Clin Pharmacol Ther. 2013 Jan;51(1):67-9. doi: 10.5414/cpp51067. Int J Clin Pharmacol Ther. 2013. PMID: 23260004 Free article. No abstract available.

10

Circulating microRNAs in serum: novel biomarkers for patients with bladder cancer?

Scheffer AR, Holdenrieder S, Kristiansen G, von Ruecker A, Müller SC, Ellinger J. Scheffer AR, et al. Among authors: holdenrieder s. World J Urol. 2014 Apr;32(2):353-8. doi: 10.1007/s00345-012-1010-2. Epub 2012 Dec 25. World J Urol. 2014. PMID: 23266581

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

281 results

Search Page

Filters